Kronos Bio Stock (NASDAQ: KRON) stock price, news, charts, stock research, profile.
You can purchase shares of Kronos Bio (NASDAQ:KRON) through any online brokerage.
Other companies in Kronos Bio’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Estrella Immunopharma (NASDAQ:ESLA), CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE) and Gain Therapeutics (NASDAQ:GANX).
Kronos Bio has a consensus price target of $7.31.
The stock price for Kronos Bio (NASDAQ: KRON) is $0.9641 last updated February 21, 2025 at 6:02 PM EST.
There are no upcoming dividends for Kronos Bio.
Kronos Bio’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Kronos Bio.
Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.